DORA: A Doravirine-based First-line Antiretroviral Therapy for Women of Reproductive Potential Living With HIV
NCT04433780
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
133
Enrollment
OTHER
Sponsor class
Conditions
HIV-1-infection
Interventions
DRUG:
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate
Sponsor
Professor Francois Venter